« Return to News | CROs/Service Providers

United Drug to acquire pharmacovigilance, market access companies

Tuesday, August 28, 2012 12:21 PM

United Drug, an international provider of healthcare services, will acquire North Carolina-based Drug Safety Alliance for a total of up to $28 million, and North Carolina-based Synopia RX for up to $12 million.

DSA employs 94 people and provides safety and risk management services supporting pharmaceutical, biotech, medical device, animal and consumer health organizations, including detection, assessment, analysis and reporting of adverse drug reactions.

United Drug said DSA complements its U.S. medical information business, Alliance, and will allow for an integrated call center and case processing pharmacovigilance service. Both DSA and Alliance will be part of United Drug’s sales, marketing & medical division.

Synopia provides market access services to pharmaceutical and biotech manufacturers in the U.S., to accelerate the access and positioning of medicines in the payer market. Services include market research, payer strategy development and account management. Synopia also will be part of United Drug’s sales, marketing & medical division.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.